OSDDMalaria:OSDD Malaria Meeting Sydney 2012 - Revision history

Matthew Todd: /* Schedule */

Matthew Todd — Wed, 22 Feb 2012 00:39:59 GMT

Schedule

←Older revision		Revision as of 00:39, 22 February 2012
Line 20:		Line 20:
	'''9 start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>		'''9 start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>
	''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran, Luigi Palombi and Hazel Moir.<br>		''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran, Luigi Palombi and Hazel Moir.<br>
-	'''11 - Coffee'''<br>	+	'''11 Coffee'''<br>
	''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens. Nico Adams and Andrew Treloar will lead a discussion on open data.<br>		''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens. Nico Adams and Andrew Treloar will lead a discussion on open data.<br>
	'''12:30 Lunch'''<br>		'''12:30 Lunch'''<br>

Matthew Todd: /* Schedule */ updated schedule

Matthew Todd — Wed, 22 Feb 2012 00:39:41 GMT

Schedule: updated schedule

←Older revision		Revision as of 00:39, 22 February 2012
Line 19:		Line 19:

	'''9 start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>		'''9 start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>
-	''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran ~~and~~ Luigi Palombi.<br>	+	''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran, Luigi Palombi and Hazel Moir.<br>
	'''11 - Coffee'''<br>		'''11 - Coffee'''<br>
-	''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens.<br>	+	''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens. Nico Adams and Andrew Treloar will lead a discussion on open data.<br>
	'''12:30 Lunch'''<br>		'''12:30 Lunch'''<br>
-	''Afternoon session 1:'' What are the most significant types of drugs needed for the treatment of malaria? Paul Willis will lead a survey of current treatments.<br>	+	''Afternoon session 1:'' What are the most significant types of drugs needed for the treatment of malaria? Paul Willis will lead a survey of current treatments and MMV's hit-to-lead criteria. Stuart Ralph will describe which screening approaches could become standard for an open drug discovery project.<br>
	'''3 Coffee'''<br>		'''3 Coffee'''<br>
-	''Afternoon session 2:'' Which compounds should we pursue? Who should do it? How?<br>	+	''Afternoon session 2:'' Which compounds should we pursue? Who should do it? How? Saman Habib will describe the OSDDm project in India, centered at CDRI Lucknow.<br>
	'''5 Drinks and dinner'''<br>		'''5 Drinks and dinner'''<br>

Matthew Todd: /* Open Source Drug Discovery for Malaria - February 24th 2012 */ added note about sponsorship

Matthew Todd — Tue, 21 Feb 2012 06:49:53 GMT

Open Source Drug Discovery for Malaria - February 24th 2012: added note about sponsorship

←Older revision		Revision as of 06:49, 21 February 2012
Line 10:		Line 10:

	However, the views expressed during the day should be taken as those of the individuals and not of the organizations they represent.<br>		However, the views expressed during the day should be taken as those of the individuals and not of the organizations they represent.<br>
		+
		+	This event is made possible by financial support from the University of Sydney's International Program Development Fund and the Medicines for Malaria Venture, as well as logistical support from the School of Chemistry at The University of Sydney.<br>

	===Location Information===		===Location Information===

Matthew Todd: /* Schedule */

Matthew Todd — Tue, 21 Feb 2012 05:46:18 GMT

Schedule

←Older revision		Revision as of 05:46, 21 February 2012
Line 16:		Line 16:
	===Schedule===		===Schedule===

-	'''9 ~~a.m.~~ start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>	+	'''9 start''' Welcome by Mat Todd and opening remarks by Mary O'Kane, NSW Chief Scientist.<br>
	''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran and Luigi Palombi.<br>		''Morning session 1:'' What is the current status of drug discovery and development (with some focus on malaria)? Sessions to be led by Mary Moran and Luigi Palombi.<br>
	'''11 - Coffee'''<br>		'''11 - Coffee'''<br>
	''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens.<br>		''Morning session 2:'' What is the scientific and economic case for open source drug discovery? Mat Todd and his team will describe what open science is, and how it can be done. Richard Jefferson will demo the patent lens.<br>
-	'''~~1-2~~ Lunch'''<br>	+	'''12:30 Lunch'''<br>
	''Afternoon session 1:'' What are the most significant types of drugs needed for the treatment of malaria? Paul Willis will lead a survey of current treatments.<br>		''Afternoon session 1:'' What are the most significant types of drugs needed for the treatment of malaria? Paul Willis will lead a survey of current treatments.<br>
-	'''3~~:30-4 Break~~'''<br>	+	'''3 Coffee'''<br>
	''Afternoon session 2:'' Which compounds should we pursue? Who should do it? How?<br>		''Afternoon session 2:'' Which compounds should we pursue? Who should do it? How?<br>
-	'''5 ~~p.m.~~ Drinks and dinner'''<br>	+	'''5 Drinks and dinner'''<br>

	Sessions will broadly address these questions:<br>		Sessions will broadly address these questions:<br>

Matthew Todd: /* Open Source Drug Discovery for Malaria - February 24th 2012 */ disclaimer

Matthew Todd — Tue, 21 Feb 2012 01:17:20 GMT

Open Source Drug Discovery for Malaria - February 24th 2012: disclaimer

←Older revision		Revision as of 01:17, 21 February 2012
Line 6:		Line 6:

	This link will take you to the live feed when the conference is running: '''http://bit.ly/OSDDmeeting'''<br>		This link will take you to the live feed when the conference is running: '''http://bit.ly/OSDDmeeting'''<br>
		+
		+	Please note that this meeting will be broadcast live, and anyone may input - either on the streaming site above, or using the '''Twitter hashtag #osddmalaria'''<br>
		+
		+	However, the views expressed during the day should be taken as those of the individuals and not of the organizations they represent.<br>

	===Location Information===		===Location Information===

Matthew Todd: /* Streaming/Archiving */

Matthew Todd — Sun, 19 Feb 2012 21:40:11 GMT

Streaming/Archiving

←Older revision		Revision as of 21:40, 19 February 2012
Line 81:		Line 81:

	===Streaming/Archiving===		===Streaming/Archiving===
-	~~Link will appear here~~:<br>	+	'''http://bit.ly/OSDDmeeting'''<br>

Matthew Todd: /* Open Source Drug Discovery for Malaria - February 24th 2012 */ added link to stream

Matthew Todd — Sun, 19 Feb 2012 21:39:15 GMT

Open Source Drug Discovery for Malaria - February 24th 2012: added link to stream

←Older revision		Revision as of 21:39, 19 February 2012
Line 5:		Line 5:
	There will be a one-day meeting on Open Source Drug Discovery for Malaria at The University of Sydney, 24th February 2012. Rather than a series of presentations, this meeting will be run [http://en.wikipedia.org/wiki/Unconference unconference] style, driven by what people wish to discuss. An approximate schedule is shown below, detailing the questions we need to answer during the day. The meeting will be live streamed, and archived. Anyone watching can ask questions or comment via their web browser.<br>		There will be a one-day meeting on Open Source Drug Discovery for Malaria at The University of Sydney, 24th February 2012. Rather than a series of presentations, this meeting will be run [http://en.wikipedia.org/wiki/Unconference unconference] style, driven by what people wish to discuss. An approximate schedule is shown below, detailing the questions we need to answer during the day. The meeting will be live streamed, and archived. Anyone watching can ask questions or comment via their web browser.<br>

-	This link will take you to the live feed when the conference is running: ''~~TBA~~''<br>	+	This link will take you to the live feed when the conference is running: '''http://bit.ly/OSDDmeeting'''<br>

	===Location Information===		===Location Information===

Jim Cronshaw: put a small edit on one of the questions, asking about the economic barriers to open science (eg: what are the incentives to large corporations?)

Jim Cronshaw — Sun, 19 Feb 2012 02:29:27 GMT

put a small edit on one of the questions, asking about the economic barriers to open science (eg: what are the incentives to large corporations?)

←Older revision		Revision as of 02:29, 19 February 2012
Line 28:		Line 28:
	* What technical barriers prevent open science?		* What technical barriers prevent open science?
	* Which licence governs an open source drug discovery project?		* Which licence governs an open source drug discovery project?
-	* What psychological/professional barriers are there to open science?	+	* What psychological/professional/economic barriers are there to open science?
	* Is there a danger that open source drug discovery can be hijacked by people taking all the data and patenting them?		* Is there a danger that open source drug discovery can be hijacked by people taking all the data and patenting them?
	* Who might participate?		* Who might participate?

Matthew Todd: /* Location Information */

Matthew Todd — Tue, 14 Feb 2012 21:45:31 GMT

Location Information

←Older revision		Revision as of 21:45, 14 February 2012
Line 8:		Line 8:

	===Location Information===		===Location Information===
-	The meeting will take place in Lecture Theatre ~~026~~ in the [http://sydney.edu.au/law/about/campus.shtml New Law building] on the main Camperdown campus of The University of Sydney. An internal map of the building is [http://sydney.edu.au/law/about/docs_pdfs/Law%20Faculty%20Teaching%20Spaces.pdf here] (PDF). Convenient parking is available, but please contact Mat Todd if this is needed.	+	The meeting will take place in Lecture Theatre 106 in the [http://sydney.edu.au/law/about/campus.shtml New Law building] on the main Camperdown campus of The University of Sydney. An internal map of the building is [http://sydney.edu.au/law/about/docs_pdfs/Law%20Faculty%20Teaching%20Spaces.pdf here] (PDF). Convenient parking is available, but please contact Mat Todd if this is needed.

	===Schedule===		===Schedule===

Paul M. Ylioja: /* Invited */

Paul M. Ylioja — Mon, 13 Feb 2012 03:21:54 GMT

Invited

←Older revision		Revision as of 03:21, 13 February 2012
Line 69:		Line 69:
	* [http://www.qimr.edu.au/page/Lab/Malaria_Drug_Resist_Chemo/ Michelle Gatton]		* [http://www.qimr.edu.au/page/Lab/Malaria_Drug_Resist_Chemo/ Michelle Gatton]
	* [http://www.discoverybiology.org/team/vicky-avery Vicky Avery], Discovery Biology, Griffith University		* [http://www.discoverybiology.org/team/vicky-avery Vicky Avery], Discovery Biology, Griffith University
		+	* Laura White, Open Science TSP student, School of Chemistry, University of Sydney

	===Potential Invitees===		===Potential Invitees===